Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
CrossRef Assessing the developing pharmacotherapeutic landscape in hepatitis B treatment: a spotlight on drugs in phase II clinical trials Rex Wan-Hin Hui, Lung Yi Mak, Wai-Kay Seto, Man-Fung Yuen Expert Opinion on Emerging Drugs .2022
This article is for educational purposes only and does not replace the advice of a qualified healthcare or nutrition professional
Retrieved from Betancourt-Nez, A., Torres-Castillo, N., Martnez-Lpez, E., et al
4), 1825 nucleotides in length, are well characterized as post-transcriptional regulators of mRNAs 73,74 and are considered a potential source of biomarkers for many diseases, including cancer 75
US$ 22.08
US$ 26.51
US$ 25.83
US$ 24.43
US$ 26.77
